Malignant Reproductive System Neoplasm — Trials

Malignant Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,155 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,803
Recruiting: 1,544
Ph III recruiting: 175
Growth YoY: +15.7%
Industry share: 21%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,473)

clinicaltrialsPublishedShowing 201–250 of 1,061 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05797168	Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors(FONTANA)	recruiting	Phase 1 / Phase 2	602	AstraZenecaINDUSTRY	12	Aug 21, 2026	clinicaltrials
NCT06365853	A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression	active not recruiting	Phase 2	108	AbbVieINDUSTRY	7	Aug 21, 2026